Silverarc Capital Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Silverarc Capital Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-124,353	Closed	-$4.14M	–	85
2024 Q3	$4.14M	Buy	124,353 +1,504	+1%	+$51.8K	0.93%	35
2024 Q2	$3.32M	Buy	+122,849	New	+$2.42M	0.78%	36

Silverarc Capital Management's LBPH Position: Q4 2024 in Review

Silverarc Capital Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 124,353 shares — an estimated $4.14M sold.

Silverarc Capital Management first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $4.14M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Silverarc Capital Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Silverarc Capital Management sold 124,353 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $4.14M.
Silverarc Capital Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Silverarc Capital Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $4.14M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Silverarc Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.